Finn C. Nielsen

2.2k total citations
14 papers, 271 citations indexed

About

Finn C. Nielsen is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Finn C. Nielsen has authored 14 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 7 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Finn C. Nielsen's work include BRCA gene mutations in cancer (10 papers), CRISPR and Genetic Engineering (5 papers) and Cancer Genomics and Diagnostics (5 papers). Finn C. Nielsen is often cited by papers focused on BRCA gene mutations in cancer (10 papers), CRISPR and Genetic Engineering (5 papers) and Cancer Genomics and Diagnostics (5 papers). Finn C. Nielsen collaborates with scholars based in Denmark and Sweden. Finn C. Nielsen's co-authors include Thomas van Overeem Hansen, Lars Jønson, Anne‐Marie Gerdes, Bent Ejlertsen, Lise Barlebo Ahlborn, Friedrik P. Wikman, Marie Luise Bisgaard, Lone Sunde, Lennart Friis‐Hansen and Mads Thomassen and has published in prestigious journals such as Breast Cancer Research and Treatment, European Journal of Human Genetics and Acta Oncologica.

In The Last Decade

Finn C. Nielsen

14 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Finn C. Nielsen Denmark 12 166 157 73 46 32 14 271
Wera Hofmann Germany 9 201 1.2× 240 1.5× 66 0.9× 57 1.2× 43 1.3× 13 322
Sourat Darabi United States 9 93 0.6× 66 0.4× 69 0.9× 32 0.7× 83 2.6× 46 246
Gemma D’Elia Italy 8 210 1.3× 97 0.6× 134 1.8× 15 0.3× 24 0.8× 10 333
A. Barroso Spain 11 125 0.8× 167 1.1× 43 0.6× 43 0.9× 40 1.3× 16 273
Ingrid Petroni Ewald Brazil 8 149 0.9× 164 1.0× 79 1.1× 31 0.7× 109 3.4× 12 288
Cecília Correia Portugal 12 124 0.7× 53 0.3× 48 0.7× 58 1.3× 32 1.0× 25 267
Arvīds Irmejs Latvia 10 101 0.6× 100 0.6× 92 1.3× 41 0.9× 65 2.0× 38 215
Petra E.A. Huijts Netherlands 7 120 0.7× 133 0.8× 91 1.2× 76 1.7× 63 2.0× 7 272
Regina Kroiss Austria 10 156 0.9× 196 1.2× 110 1.5× 107 2.3× 116 3.6× 11 388
B Dębniak Poland 9 87 0.5× 76 0.5× 52 0.7× 32 0.7× 103 3.2× 11 229

Countries citing papers authored by Finn C. Nielsen

Since Specialization
Citations

This map shows the geographic impact of Finn C. Nielsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Finn C. Nielsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Finn C. Nielsen more than expected).

Fields of papers citing papers by Finn C. Nielsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Finn C. Nielsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Finn C. Nielsen. The network helps show where Finn C. Nielsen may publish in the future.

Co-authorship network of co-authors of Finn C. Nielsen

This figure shows the co-authorship network connecting the top 25 collaborators of Finn C. Nielsen. A scholar is included among the top collaborators of Finn C. Nielsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Finn C. Nielsen. Finn C. Nielsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Schmidt, Ane Yde, Thomas van Overeem Hansen, Lise Barlebo Ahlborn, et al.. (2017). Next-Generation Sequencing–Based Detection of Germline Copy Number Variations in BRCA1 / BRCA2. Journal of Molecular Diagnostics. 19(6). 809–816. 20 indexed citations
2.
Jønson, Lars, Lise Barlebo Ahlborn, Bent Ejlertsen, et al.. (2016). Identification of six pathogenic RAD51C mutations via mutational screening of 1228 Danish individuals with increased risk of hereditary breast and/or ovarian cancer. Breast Cancer Research and Treatment. 155(2). 215–222. 22 indexed citations
3.
Bennedbæk, Marc, Maria Rossing, Åse Krogh Rasmussen, et al.. (2016). Identification of eight novel SDHB, SDHC, SDHD germline variants in Danish pheochromocytoma/paraganglioma patients. Hereditary Cancer in Clinical Practice. 14(1). 13–13. 12 indexed citations
4.
Ahlborn, Lise Barlebo, et al.. (2015). Splicing analysis of 14 BRCA1 missense variants classifies nine variants as pathogenic. Breast Cancer Research and Treatment. 150(2). 289–298. 25 indexed citations
5.
Jønson, Lars, et al.. (2014). Functional characterization of BRCA1 gene variants by mini-gene splicing assay. European Journal of Human Genetics. 22(12). 1362–1368. 48 indexed citations
6.
Rossing, Maria, Anne‐Marie Gerdes, Anders Juul, et al.. (2014). A novel DICER1 mutation identified in a female with ovarian Sertoli-Leydig cell tumor and multinodular goiter: a case report. Journal of Medical Case Reports. 8(1). 112–112. 14 indexed citations
7.
Ahlborn, Lise Barlebo, et al.. (2014). Identification of a breast cancer family double heterozygote for RAD51C and BRCA2 gene mutations. Familial Cancer. 14(1). 129–133. 12 indexed citations
8.
Rasmussen, Lene Juel, Anne‐Marie Gerdes, Lotte Krogh, et al.. (2013). Functional examination of MLH1, MSH2, and MSH6 intronic mutations identified in Danish colorectal cancer patients. BMC Medical Genetics. 14(1). 103–103. 18 indexed citations
9.
Friis‐Hansen, Lennart, et al.. (2012). Identification of 3 novel VHL germ-line mutations in Danish VHL patients. BMC Medical Genetics. 13(1). 54–54. 19 indexed citations
10.
Hansen, Thomas van Overeem, Lars Jønson, Mette Klarskov Andersen, et al.. (2011). Screening of 1331 Danish breast and/or ovarian cancer families identified 40 novel BRCA1 and BRCA2 mutations. Familial Cancer. 10(2). 207–212. 3 indexed citations
11.
Thomassen, Mads, Inge Søkilde Pedersen, Ida Vogel, et al.. (2010). A BRCA2 mutation incorrectly mapped in the original BRCA2 reference sequence, is a common West Danish founder mutation disrupting mRNA splicing. Breast Cancer Research and Treatment. 128(1). 179–185. 4 indexed citations
12.
Jønson, Lars, et al.. (2010). Identification of a Danish breast/ovarian cancer family double heterozygote for BRCA1 and BRCA2 mutations. Familial Cancer. 9(3). 283–287. 14 indexed citations
13.
Hansen, Thomas van Overeem, et al.. (2009). The silent mutation nucleotide 744 G → A, Lys172Lys, in exon 6 of BRCA2 results in exon skipping. Breast Cancer Research and Treatment. 119(3). 547–550. 24 indexed citations
14.
Thomassen, Mads, Thomas van Overeem Hansen, Åke Borg, et al.. (2008). BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer. Acta Oncologica. 47(4). 772–777. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026